Abstract | For many years, the intestine was one of the poor relations of the immunology world, being a realm inhabited mostly by specialists and those interested in unusual phenomena. However, this has changed dramatically in recent years with the realization of how important the microbiota is in shaping immune function throughout the body , and almost every major immunology institution now includes the intestine as an area of interest. One of the most important aspects of the intestinal immune system is how it discriminates carefully between harmless and harmful antigens, in particular, its ability to generate active tolerance to materials such as commensal bacteria and food proteins. This phenomenon has been recognized for more than 100 years, and it is essential for preventing inflammatory disease in the intestine, but its basis remains enigmatic. Here, I discuss the progress that has been made in understanding oral tolerance during my 40 years in the field and highlight the topics that will be the focus of future research.
The intestine has a long history as an immunological organ, with its lymphocytes and organized lymphoid tissues having been discovered many years ago, even if their functions were not fully understood at the time. When I started in the field more than 40 years ago, it was already known that there were more lymphocytes in the intestine than in any other part of the body, which of course makes complete sense when one considers its constant exposure to microorganisms and other external antigens. However, until very recently, intestinal immunology was neglected by mainstream immunologists. The gut was held to be a dirty and complicated tissue that was difficult to work with and where experimental findings were at best phenomenology rather than precise data of immunological importance. This attitude has been transformed in recent years, in great part because of the realization that the intestinal microbiota plays a crucial role in shaping immune function and susceptibility to disease. As a result, the intestine is now After completing a PhD with Anne, immune regulation in the intestine has continued to be the focus of my research ever since. In this Timeline article, I provide a personal perspective on the key discoveries that have shaped our current understanding of immunological tolerance in the intestine, often referred to simply as oral tolerance (Fig. 1) . Strictly speaking, however, this term should be used for only the local and systemic hyporesponsiveness to subsequent challenge that occurs when exogenous antigens are administered by the oral route. This is one aspect of the more general phenomenon of mucosal tolerance that characterizes the failure of all steady-state mucosal surfaces to make effector responses against harmless materials of all kinds.
Oral tolerance -historical aspects
The first serious interest in the intestine as an immunological organ came about because of the epidemics of typhoid, cholera and other intestinal infections that were prevalent when microbiology and immunology were developing as disciplines in the late 19th century. At this time, sporadic attempts were made to vaccinate individuals orally with relevant microorganisms, some of which were partially successful. However, it also became apparent from these kinds of experiments that non-living materials were ineffective in inducing active immunity in the intestine. In 1911, Wells and Osborne demonstrated that oral administration of proteins such as ovalbumin prevented subsequent local and systemic anaphylactic reactions to these proteins in guinea pigs 1 . By 1930, it had been shown that prior feeding of contact-sensitizing agents prevented dermal hypersensitivity to these agents -the Sulzberger-Chase phenomenon 2 . Even at this early stage, the experimental tolerance that was induced by oral administration of antigens was found to be antigenspecific, and evidence was then obtained that tolerized lymphocytes were rendered intrinsically and permanently unresponsive 3 . However, it was not until 1994 that the ability of orally administered antigens to induce systemic tolerance was demonstrated formally in humans, which was shown when feeding the novel antigen keyhole limpet haemocyanin was found to inhibit seen as a fulcrum of the immune system, and there is increasing interest in exploring its unusual aspects and understanding how these might influence immunity elsewhere.
One of the most characteristic and longest known features of the intestinal immune system is its ability to develop tolerance to the wealth of harmless foreign antigens it encounters on a routine basis and yet still generate active immunity against pathogens. As well as being fundamental to understanding the pathogenesis of inflammatory bowel diseases and to creating orally active vaccines, this balancing act in the intestinal immune system is also the best physiological example of how innate immune signals are constantly being integrated to regulate adaptive immune responses. I first became fascinated by this phenomenon as a medical student in the mid-1970s when carrying out an elective project with the late Anne Ferguson, whose research interest was in coeliac disease and who was then at the forefront of the emerging field of mucosal immunology. subsequent delayed-type hypersensitivity (DTH) responses after skin challenge 4 .
Mechanisms of oral tolerance to protein antigens. What became known as oral tolerance was first explored in immunological detail in the 1970s and 1980s, when its scope and mechanistic basis were documented. Among the insights that emerged was the finding that the oral route of antigen delivery was a particularly efficient way of inducing tolerance 5 . It also became clear that soluble antigens such as proteins were able to induce tolerance when given orally, whereas antigens in the form of particles or as part of a live organism were more likely to provoke active immunity. Even though these studies were conducted before the importance of the innate immune system, co-stimulation and danger signals had been appreciated, they were already seen as evidence that tolerance reflected an inability to activate the antigen presentation limb of the immune response in such a way that lymphocytes were not primed properly 5 . It was also shown that while oral tolerance could affect all aspects of the immune response, it was particularly effective at inhibiting responses that could cause damage to the host, such as T cell-mediated DTH reactions and immunoglobulin E (IgE)-dependent responses. Thus, the idea was already forming that tolerance to harmless antigens in the intestine was a physiologically crucial phenomenon designed to prevent pathological conditions directed at, for example, food proteins 5 . The tolerance described in these early studies could be transferred to naive animals by lymphocytes, and as with many other aspects of immune regulation at the time, it was proposed that this was dependent on a population of CD8 + suppressor T cells; oral tolerance could also be prevented by depleting such cells in vivo 6 . However, this aspect of immunology collapsed dramatically in the late 1980s, as increasing knowledge of T cell biology and MHC restriction indicated that there was no molecular basis for antigen-specific CD8 + T cells to function in this way. Indeed, the original observations implicating this population have never been explained satisfactorily in the intervening years, and in the 1990s, attention turned to the emerging immunoregulatory mechanisms that involved CD4 + T cells. A debate in cellular immunology at this time was whether cell intrinsic mechanisms such as clonal deletion and anergy could account for tolerance in T cells or whether this involved extrinsic control P e r s P e c t i v e s Pro-inflammatory, microbiota-specific CD4 + T cells are present in the normal immune system 23, 24 Identification of coeliac disease by active inhibitory mechanisms. In the 1990s, Howard Weiner and colleagues proposed that which of these mechanisms was involved in oral tolerance might be determined by the antigen dose regime used. Whereas single high doses of protein antigen were thought to cause anergy and/or deletion of antigen-specific T cells, multiple feeds of lower doses were predicted to generate regulatory T (T reg ) cells 7 . This was important because of the ideas that arose around this time of harnessing oral tolerance for treating immunological diseases (see below). Specifically, it was considered that active T reg cells would be more useful for this purpose. This was because of their ability to persist and to produce cytokines that would generate 'bystander' suppression by acting on effector T cells with different specificities, something that would help overcome the epitope spreading that is a feature of many autoimmune disorders. Although some evidence was presented that clonal deletion of antigen-specific T cells could be induced in oral tolerance, this was found after feeding very large doses of antigen to full T cell receptor transgenic mice, a system that was unlikely to represent the usual situation in vivo 8 . In general, it was never proved experimentally that clonal deletion and/or anergy could contribute to oral tolerance in the presence of a polyclonal T cell repertoire using physiological amounts of antigen. Indeed, subsequent experiments suggest that the higher the dose of antigen fed, the better the induction of T reg cells 9 .
Regulatory T cells enter the fray.
In common with other aspects of immune regulation, most studies of oral tolerance in the past 20 years have focused on the possible role of T cells with active inhibitory properties and particularly on CD4 + T reg cells. Before this subset itself was defined, regulation of T cell function in oral tolerance was proposed to be an example of the T helper 1 (T H 1)-T H 2 paradigm that dominated cellular immunology for some time. This was an attractive idea, as oral tolerance seemed to be particularly effective in suppressing DTH responses, and it was thought that this might be due to preferential activation of T H 2 cells 7 . However, this could not explain why IgE production, which is a signature T H 2 cellmediated function, was also very easy to tolerize by feeding antigen. As a result, the paradigm was modified to accommodate findings that a population of transforming growth factor-β (TGFβ)-secreting CD4 + T cells (at the time proposed to be T H 3 cells) was associated with oral tolerance 10 . is essentially ignorant of its presence 28 ( Fig. 2) . The explanation for this comes from earlier experiments by the group of Andrew Macpherson, which showed that recognition of microbiota-derived antigens is dependent on uptake by dendritic cells (DCs) that migrate no further than the mesenteric lymph nodes (MLNs) 29 . As a result, specific immune responses to the microbiota are localized to the intestinal mucosa and involve the generation of T reg cells and secretory IgA production. Studies of the mechanisms underlying IgA class switching and the induction of T reg cells indicated that a common factor could be the cytokine TGFβ, and it has been suggested subsequently that T reg cells themselves may drive IgA production in response to the microbiota 30, 31 and potentially become follicular helper T cells (T FH ) in Peyer's patches 32 .
Compartmentalization of tolerance to the microbiota makes complete biological sense, as these organisms are highly pathogenic if they escape into the body from the intestinal lumen, and therefore it is important that protective immunity can be generated under these circumstances. There are several processes that restrict access of the microbiota to the systemic immune system, including the physical barriers presented by the mucous layer and intact epithelium, as well as the innate immune defences that protect the epithelial barrier (see below).
Despite the intact organisms that make up the microbiota being kept at bay, one of the biggest developments in immunology in my time has been the recognition of how the microbiota shapes immune responses both in the intestine and elsewhere. The first example of an individual organism having this kind of effect was the ability of segmented filamentous bacteria (SFB) to drive IgA production 33 , and several years later, SFB were found to be the main factor responsible for inducing T H 17 cell responses in mice 34, 35 . Subsequent examples include the induction of IL-10-producing T reg cells by polysaccharide A from Bacteroides fragilis 36 and the ability of certain human clostridial species to expand FOXP3 + T reg cells via the local production of TGFβ and butyrate [37] [38] [39] . It is now accepted that these effects of the microbiota are not restricted to the intestine and that the microbiota influences many aspects of biology throughout the body, including susceptibility to numerous diseases 40 . Furthermore, the intestine is by no means the only source of commensal microorganisms, and without doubt, these topics will be one of the main areas of research in the foreseeable future.
Again, these cells were never characterized in full, and this work was conducted before the discovery of the transcription factor forkhead box protein P3 (FOXP3) or what we would now consider as bona fide T reg cells. The first evidence supporting a role for such cells in oral tolerance came from studies using surrogate markers for T reg cells, such as CD25, showing that tolerance could be transferred by CD4
+ T cells co-expressing such markers [11] [12] [13] [14] . Control of oral tolerance by FOXP3
+ T reg cells was eventually shown directly in 2007 15 and has since been confirmed in various systems 16, 17 . Indeed, it seems that most 'inducible' T reg cells in the steady-state small intestine may be specific for food antigens 17 . The mechanism of action for these cells is usually assumed to involve production of TGFβ, but as yet, there is little direct evidence for this.
The intestinal microbiota
The presence of bacteria in the normal intestine has been known from the start of microbiology as a discipline, and their contribution to host metabolism and other aspects of health has been appreciated for many years. Furthermore, germ-free animals have very reduced immune responses and much smaller lymphoid organs 18, 19 . An obvious problem for immunologists was how the immune system could cope with this enormous burden of foreign antigen without attempting to reject it. The simplistic assumption that the microorganisms were simply not visible to immune cells became untenable when it was shown that the large amount of secretory IgA antibodies present in the normal intestine is directed mostly at the bacteria that make up the microbiota 20 . Indeed, it was then suggested that one of the principal roles of IgA was to prevent access of commensal bacteria to the body (the concept of immune exclusion 21 ), and in support of this, subsequent studies have shown that a substantial proportion of commensal bacteria in the colon are coated with IgA 22 . In the mid-1990s, the groundbreaking studies of Fiona Powrie and others showed that the normal immune system also contained effector T cells that could recognize the microbiota 23, 24 . However, these are normally kept in check by T reg cells, which were shown to act via the production of IL-10 (ReF.
25
) or TGFβ 26 , consistent with the spontaneous colitis that had been found in IL-10-deficient mice when they were first described 27 . Unlike the situation with protein antigens encountered in the gut, tolerance to the gut microbiota is compartmentalized to the intestine, and the systemic immune system T cells in oral tolerance described these cells in Peyer's patches 42 , while both the clonal deletion of antigen-specific T cells and the presence of CD4 + T cells with inhibitory properties were subsequently described in the Peyer's patches of protein-fed mice 8, 43 . Nevertheless, a number of studies have shown that surgical or developmental removal of Peyer's patches does not alter the induction of oral tolerance to proteins (reviewed in ReF. 44 ), and in recent years, attention has turned more to the idea that the relevant antigen is acquired by DCs in the villus lamina propria and transported by these cells to the draining MLNs where the induction of T reg cells occurs (Fig. 2) .
Studies by the group of Oliver Pabst and others have confirmed that both the migration of DCs and the induction of oral tolerance are dependent on CC-chemokine receptor 7 (CCR7) and suggested that events in MLNs drive the systemic consequences of tolerance 45, 46 . However, it is not known how the MLNs can influence the immune system outside of the intestine. Furthermore, the earliest studies in which antigen-specific CD4 + T cells could be tracked directly found that orally administered antigen . This systemic dissemination of antigen was consistent with work from the 1980s showing that ingested proteins are present in an immunologically relevant form in the circulation of healthy humans and mice 5, 47, 48 . In mice, this material was shown to be tolerogenic when transferred to normal recipients, and together, these findings could explain the systemic consequences of oral tolerance without a specific role for the MLNs. While these apparent contradictions have not yet been explained, it seems quite possible that both processes may contribute to oral tolerance to soluble antigens, with their relative importance depending, for instance, on the dose, size and nature of the antigen.
A further issue that has never been resolved is whether the liver plays any role in the systemic consequences of oral tolerance. This is an attractive idea, as materials emanating from the intestine in the bloodstream drain directly to the liver via the portal vein, and direct administration of antigen into the portal vein induces a state of systemic tolerance that appears to be rather similar to oral tolerance 49 . However, older experiments in which tolerance was prevented when the portal circulation was disrupted or when Kupffer cells were depleted using the heavy metal gadolinium have proved difficult to interpret owing to toxicity issues 49 . Similarly, the studies suggesting that liver sinusoidal endothelial cells 50 or plasmacytoid DCs 51 act as tolerogenic antigen-presenting cells (APCs) for oral antigens still await full explanation. This is an area that deserves to be revisited with more modern and precise approaches, such as exploiting the recently described marker C-type lectin domain family 4 member F (CLEC4F), which allows highly selective deletion of Kupffer cells in vivo 52 . While accepting these uncertainties, the current consensus is that the DCs present in the lamina propria play a crucial role in determining immune responsiveness to protein antigens in the intestine (Fig. 2) ; the characterization of these cells has been a central focus of many groups in mucosal immunology in the past 10 years, including my own. In large part, this reflects the advances in flow cytometry and molecular biology that now allow small populations of cells from tissues to be analysed in depth. Nevertheless, it is important to point out that the intestine was one of the first tissues in which MHC class II (MHCII) + DCs were identified when research into such cells was in its infancy 53 . Later work showed that expansion of DC numbers in vivo using the FMS-related tyrosine kinase 3 ligand (FLT3L) growth factor could increase the induction of oral tolerance, and in fact, this was one of the first demonstrations that DCs could induce tolerance as well as prime effector responses in the immune system 54 .
The first experiments using DCs isolated from the intestine described a population in Peyer's patches that produced IL-10 selectively 55 . This was followed by findings that CD11c + MHCII + APCs could be isolated from the small intestinal lamina propria of antigen-fed mice and that these APCs induced tolerance to the fed antigen when transferred into recipients that had not been exposed to the antigen 56 . As with much other work at that time, the identification of these mucosal APCs as DCs became complicated by the realization that they shared many markers with macrophages, and it was not until very recently that it was shown using definitive markers that bona fide conventional DCs are required for the induction of oral tolerance 57 . In the meantime, it had been shown that CD103 was expressed by most lamina propria DCs 58 , although much earlier studies had inadvertently used CD103 to identify DCs migrating in lymph from the intestinal mucosa in rats 59 . The newly defined CD103 + DCs in mice were found to be responsible for the uptake of orally administered antigen 60 and to preferentially promote the generation of T reg cells in vitro via their selective production of retinoic acid (RA), ◀ © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. 
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P e r s P e c t i v e s Fig. 2 | Induction and maintenance of oral tolerance. Soluble antigens such as food proteins are likely
CD11b
-cDC1s will be the DCs involved 71, 128 . Both these subsets of DC migrate constitutively in afferent lymph to the draining mesenteric lymph node (MLN), where they meet naive CD4 + and CD8 + T cells. Production of retinoic acid (RA) by the DCs during the cognate interaction with T cells induces the expression of forkhead box protein P3 (FOXP3) together with the gut-homing molecules CC-chemokine receptor 9 (CCR9) and α4β7 integrin, leading to the generation of regulatory T (T reg ) cells capable of returning to the intestinal mucosa. The generation of T reg cells is also promoted by the presence of transforming growth factor-β (TGFβ), which can be converted from its latent, inactive form (iTGFβ) into the active cytokine (aTGFβ) via the action of αvβ8 integrin expressed selectively by CD103 + CD11b − DCs 71 . After leaving the MLN, CD4 +
FOXP3
+ T reg cells migrate to the lamina propria via efferent lymph and the bloodstream. Here, they prevent the activation of naive and effector T cells via the expression of cytotoxic T lymphocyte antigen 4 (CTL A4), which removes CD80 and CD86 from antigenpresenting cells (APCs) and by production of the cytokines IL-10 and TGFβ, which inhibit both APCs and T cells. IL-10 produced by resident CX 3 C-chemokine receptor 1 (CX 3 CR1) hi macrophages helps maintain FOXP3 expression by CD4
+ T reg cells in the mucosa and is needed for their survival 16, 99 . As these macrophages also express high levels of MHC class II, they may also be able to undergo cognate interactions with specific CD4 +
+ T reg cells, providing a second signal for survival, but this has not been shown directly as yet. Similarly , it has been hypothesized, but not proved, that CD4 + FOXP3 + T reg cells that have been primed in the MLNs and spent time in the mucosa may be involved in the systemic consequences of oral tolerance to protein antigens, requiring them to have exited the mucosa in lymph and migrated throughout the body via the bloodstream 16 . An alternative explanation for systemic tolerance comes from evidence that orally administered antigens can be found in lymph and the bloodstream, enabling access to resident DCs in MLNs and peripheral lymph nodes 47 ,129 . These DCs remain to be characterized but they could induce tolerance in CD4 + T cells via anergy or deletion or by generating T reg cells as a consequence of the lack of co-stimulation that characterizes secondary lymphoid organs in the steady state. Commensal microorganisms gain access to the immune system mainly by transcytosis via microfold (M) cells in the epithelium of Peyer's patches and isolated lymphoid follicles (ILFs). The antigens are then transferred to underlying DCs, probably belonging to the CD103
−

CD11b
+ subset of cDC2s. These DCs may then present antigen directly to naive CD4 + T cells in the Peyer's patches or ILFs or after migration to the draining MLN. Although this generates a FOXP3 + T reg cell that can migrate to the mucosa and has similar properties to those induced by soluble antigens, the roles of RA , TGFβ and other DC subsets in these processes are unclear. An additional feature of the immune response to microbial antigens is the production of immunoglobulin A (IgA) antibodies. This is driven by CD4 + T reg cells that have migrated into the germinal centre 30, 31 . IgA-switched B cells acquire CCR9 and α4β7 integrin expression, exit from Peyer's patches and ILFs via lymph and then migrate in the bloodstream to arrive in the lamina propria as plasma cells. Unlike soluble antigens, the tolerance to microbial antigens is confined to the intestine, and the systemic immune system normally remains ignorant of these materials 28 .
which acted in cooperation with TGFβ. For these reasons, intestinal CD103 + DCs were then held to be intrinsically tolerogenic DCs -and to be the major drivers of tolerance in the intestine [61] [62] [63] . More recently, however, this field has been complicated by the findings that CD103
+ DCs in the intestine are heterogeneous in nature. While some have the CD103
SIRPα
-phenotype of the cross-presenting, interferon regulatory factor 8 (IRF8)-dependent and basic leucine zipper transcriptional factor ATF-like 3 (BATF3)-dependent 'cDC1s' in other tissues [64] [65] [66] , the majority of CD103 + DCs in the small intestine are CD103
As discussed below, these are related to the IRF4-dependent CD11b + SIRPα + 'cDC2s' found elsewhere, although they are essentially unique to the intestine in steadystate conditions (reviewed in ReF.
67
). Further complexity comes from the fact that there is an additional population of CD103 -CD11b + DCs in the intestinal lamina propria; these also produce RA but are less effective at inducing T reg cells in vitro. In the past, less rigorous gating strategies had referred to this latter population as macrophages, but they are clearly distinct, as they are F4/80 -CD64 -and express DC-specific molecules such as FLT3 and the transcription factor zinc-finger and BTB domain-containing protein 46 (ZBTB46) 68 . It is still unclear exactly which of these DC subsets is responsible for oral tolerance, although very recent results suggest that the IRF8-dependent CD103
+
CD11b
-DCs are not involved in the case of soluble antigens 57 and that this may be driven mostly by CD103
+
CD11b
+ DCs in the small intestine 69 . Interestingly, there is evidence for anatomical differences for DC subset involvement, with CD103 -
+ DCs appearing to be responsible for tolerance to soluble antigens in the colon 69 . Furthermore, CD103 
-DCs seem to be the most effective subset at driving the induction of FOXP3 + T reg cells in vitro via RA production and this is also the only mucosal DC subset that can activate TGFβ via expression of the αvβ8 integrin 67, 70, 71 . Identifying the DC involved in the induction of oral tolerance is one of the important challenges for the future as is establishing the role of specific regulatory molecules such as IL-10, TGFβ, RA or indoleamine 2,3-dioxygenase (IDO) in this process 72 . Finally, the finding that migratory DCs can transport commensal bacteria to the MLN (see above ) has not yet been translated into definitive studies of which DC subset might be responsible for establishing and maintaining tolerance to the microbiota; in the future, more precise approaches should enable the identification of these cells and establish whether there are distinct roles for DCs and macrophages.
Acquisition of antigen by intestinal dendritic cells. Several mechanisms have been suggested over the years for how antigen comes into contact with DCs in the lamina propria, which is rather a puzzle considering that the epithelial barrier is supposed to be impermeable to macromolecules (Fig. 3) . However, as noted above, there is evidence for the presence of intact proteins in serum after antigen feeding, while some immunohistochemical studies have suggested that epithelial cells deliver the peptide products of digestion into the lamina propria 73 . Epithelial cell-derived exosomes have also been proposed to deliver tolerogenic materials from the intestinal lumen to the underlying network of immune cells in the lamina propria 74 . Work using more refined techniques has since attempted to address the issue at the cellular level, with the first intravital microscopy studies proposing that a population of DCs could extend processes across the epithelium to capture antigen from the lumen 75, 76 . However, it now seems that these cells may well have been macrophages rather than DCs, as they expressed a combination of CD11c, MHCII and CX 3 C-chemokine receptor 1 (CX 3 CR1), a typical macrophage pattern. Using more refined identification approaches, subsequent intravital microscopy studies have shown that a specific transport pathway associated with goblet cells may allow access of protein antigens to underlying CD103 + DCs in the lamina propria and that this process is necessary for oral tolerance 77 . However, other work using similar techniques has suggested that CD103
+ DCs enter the epithelial layer and thus sample luminal contents directly 78 . This would be consistent with earlier in vitro work using cell lines, which showed DCs entering epithelial monolayers and forming tight junctions with the surrounding cells, thus avoiding disruption of the barrier 79 . However, the role of this process in oral tolerance has not yet been demonstrated. A similar proviso applies to the finding that the conventional villus epithelium may contain a population of M cells with the potential to sample and transport antigen 80 . Lastly, one intriguing study suggested a role for CX 3 CR1 + macrophages in oral tolerance, presenting evidence that these were the principal cell type involved in the uptake of proteins from the lumen but that they then transferred antigen to CD103 + DCs via connexin 43 (CX43)-dependent gap junctions 81 . As macrophages do not migrate to MLNs in steady-state conditions, it is likely that this transfer process must occur locally in the lamina propria itself.
Thus, these diverse technical approaches have not yet generated a consensus on how antigen gains access to intestinal DCs, and importantly, few studies have correlated events in the mucosa with subsequent immune responses. Of equal note, current immunohistological techniques have not yet allowed the subsets of DCs and macrophages present in the intestine to be located with sufficient precision in situ.
Local conditioning determines dendritic cell function. A question of intense interest
is what drives the unusual properties of intestinal DCs, such as the exclusive expression of CD103 by cDC2s in the intestine, their production of RA and their apparently tolerogenic phenotype. An obvious possibility is that these characteristics are dependent on the local tissue environment. The first evidence to support this idea came from experiments showing that human monocyte-derived DCs that were conditioned with supernatant from the Caco-2 colonic epithelial cell line could mimic the ability of isolated colonic DCs to produce IL-10 and drive the generation of T H 2 cells in vitro. This was due to the presence of thymic stromal lymphopoietin (TSLP) in the supernatant, a mediator also expressed by colonic epithelial cells in the steady state 82 . Similar work then implicated TGFβ in the ability of epithelial cells to block inflammatory cytokine production by DCs 83 . Around the same time, attention began to focus on the role of RA not just as a mediator of intestinal DC function but as a factor controlling their differentiation. Exogenous RA was first shown to induce a mucosal DC phenotype in mouse bone marrow-derived DCs as assessed by their ability to drive RA-dependent processes in T and B cells, including expression of CCR9 and α4β7 integrin and IgA class switching 84 . This evidence that RA is important for its own production by DCs was subsequently confirmed, although the exact source of the conditioning RA is not yet clear, as both epithelial cells 85 and stromal cells 86, 87 have been implicated. The primary source of retinol, from which RA is derived, is dietary vitamin A, and the delivery of retinol to lamina propria DCs in the small intestine is enhanced by its high concentration in bile, reflecting storage of retinol in the liver 88 .
As well as inducing its own production, RA may be responsible for other features of intestinal DCs, including their antiinflammatory properties and ability to drive FOXP3 + T reg cell differentiation in vitro 89, 90 . Indeed, recent studies propose that there is a specific precursor in the bone marrow for intestinal CD103
+
CD11b
+ DCs and CD103 + CD11b -DCs, whose development is dependent on RA 91 . As noted earlier, one of the most unusual aspects of the intestine is the presence of substantial numbers of CD103 ). These are not found in other steady-state tissues, where the expression of CD103 is restricted to DCs belonging to the cross-presenting population of BATF3-dependent and IRF8-dependent chemokine XC receptor 1 (XCR1) + cDC1s 92 . Within a short time of being discovered, a number of studies showed that intestinal CD103 + CD11b + DCs were related to the lineage of cDC2s that expresses signal regulatory protein-α (SIRPα), being dependent on Notch 2 (NOTCH2), IRF4 and Krueppel-like factor 4 (KLF4) for their development. Other factors that are involved include granulocyte-macrophage colonystimulating factor (GM-CSF), SIRPα and RA. However, most of these processes are generic to the cDC2 lineage 92 , and there clearly must be something distinctive about the intestinal mucosa that accounts for the unusual properties of the cDC2s in this site. In very recent studies, we have found that CD103 expression is only one of many features that differentiate CD103
+
CD11b
+
DCs from other CD11b
+ DCs
93
. Other features include the expression of triggering receptor expressed on myeloid cells 1 (TREM1), sialic acid-binding Ig-like lectin F (SIGLECF), pancreatic secretory granule membrane major glycoprotein GP2 and CD101 as well as a distinct cassette of genes. By using these markers to interrogate Cd11c-Cre-Tgfbr1 flox/flox mice, we were able to uncover a cell-intrinsic and gutspecific role for TGFβ signalling in driving the local differentiation of CD103 
CD11b
+ intermediary 93 . Further work is required to determine how TGFβ might interact with other mediators in specifying the development of these DCs and to establish its source in vivo. One such factor may be GM-CSF, which is needed for CD103
+
CD11b
+ DCs to develop, and one intriguing idea is that this may be produced by one of the other recently discovered populations of intestinal immune cells, the group 3 innate lymphoid cell (ILC3) 94 .
Maintenance of tolerance in the mucosa Soluble protein antigens. Once tolerance has been induced in the MLNs or Peyer's patches, several mechanisms operate in the mucosa itself to ensure this homeostatic state is maintained. T reg cells that differentiate first in the secondary lymphoid organs exit and migrate to the lamina propria via efferent lymphatics and blood (Fig. 2) . As with other lymphocytes whose first encounter with antigen occurred in the intestinal lymphoid tissues, it was found that a T reg cell homing to the small intestine requires the induction of α4β7 integrin and CCR9 expression on these © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. . At the basal face of the epithelium, lamina propria DCs expressing FcRn and other Fc receptors pick up and internalize the complexes. Enterocytes that have apoptosed due to senescence or after infection by a pathogen can be phagocytosed by neighbouring DCs. CX 3 Cchemokine receptor 1 (CX 3 CR1) + mononuclear phagocytes have been shown to acquire luminal antigen efficiently , and this may involve extension of processes between the cells of the epithelium without disturbing its integrity 75 . Although these cells are likely to be macrophages that cannot present antigen directly to naive T cells, they can then pass the antigen on to neighbouring CD103 + DCs for presentation to T cells, perhaps via connexin 43 (CX43)-mediated gap junctions 81 . Mucus-secreting goblet cells can act as a conduit for the delivery of soluble antigens to lamina propria CD103 + DCs, and this process appears to be important for oral tolerance 77 . CD103
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+ DCs themselves might also enter the epithelial layer and capture bacteria before returning to the lamina propria 131 .
cells by RA-producing DCs 95 . In parallel, oral tolerance to protein antigens was shown to be defective in mice lacking these homing molecules 95 . An important insight into what might regulate the behaviour of T reg cells once they arrive in the small intestinal lamina propria came from studies by Oliver Pabst's group, which showed that IL-10 produced from CX 3 CR1
+ lamina propria macrophages was needed to maintain local expansion of the FOXP3 + T reg cell populations involved in oral tolerance to proteins 16 . Intriguingly, this study also concluded that some of the T reg cell populations that expand in the lamina propria then leave the mucosa and are responsible for the systemic consequences of oral tolerance (Fig. 2) . While this idea would be consistent with older work showing that antigen-experienced CD4
+ T cells are present in efferent lymph coming from the intestine 96 , it remains to be proved directly.
The microbiota. As noted above, it has been known for many years that IL-10 is also important for maintaining tolerance to the microbiota in the large intestine. With the discovery that macrophages in the colonic lamina propria produce substantial amounts of IL-10 constitutively 97 and the findings that lamina propria macrophages could drive the generation of FOXP3 + T reg cells in vitro 98, 99 , it seemed sensible to suggest that macrophage-derived IL-10 was the crucial factor in preventing intestinal inflammation. However, recent work has challenged this idea by showing that whereas conditional deletion of the IL-10 receptor (IL-10R) in macrophages in Cx3cr1-CreIl10r flox/flox mice leads to spontaneous colitis, deletion of IL-10 itself in macrophages does not 100 . This supports earlier work showing that Lyz2-Cre-Stat3 flox/flox mice (in which macrophages cannot respond to IL-10) also develop spontaneous intestinal inflammation 99, 101 . Thus, it appears that signalling via the IL-10R on macrophages is needed to maintain tolerance to the microbiota, whereas other cells, probably CD4 + T cells, are responsible for producing the IL-10. A further recent idea to explain the lack of a local inflammatory response to the microbiota is that MHCII + ILC3s may induce cell death in microbiotaspecific CD4
+ T cells, although this possibility remains to be confirmed 102 . The mechanisms governing the migration of microbiota-specific T reg cells to the colon are still not understood in any detail, although recently, it was proposed that G protein-coupled receptor 15 (GPR15) might fulfil this role 103 .
Intestinal disease
In the past 20 years, it has become widely accepted that when tolerance in the intestine fails, inflammatory disease ensues. An early indication of this was the finding that Il10 -/-mice developed spontaneous inflammatory bowel disease (IBD) and that this was dependent on the presence of commensal bacteria 27 . More recently, it was shown that nonfunctional mutations in IL10 or its receptor pathway in humans leads to early-onset IBD 104 . Many subsequent studies in mice have confirmed that a breakdown in the processes that underpin symbiosis between the host and their microbiota can lead to IBD 40 . The first studies examining genetic susceptibility to Crohn's disease showed an association between nonfunctional mutations in NOD2 and ileal Crohn's disease 105, 106 . Since then, Crohn's disease has become one of the best understood inflammatory disorders at the genetic level, with most susceptibility genes coding for factors involved in innate defence mechanisms used by myeloid cells and the epithelial barrier to deal with bacteria. These include CARD9, IL23R, TNFSF15, ATG16L1 (which promotes autophagy in Paneth cells) and the autophagy-related IRGM gene (reviewed in ReF. . Around the same time, the main antigenic peptides in gliadin were identified and their molecular interactions with the disease-specific HLA-DQ2 molecule were elucidated, as was the essential role of the tissue transglutaminase in generating the peptides 113, 114 . Despite this wealth of knowledge on the clinical disorder, it has never been shown directly that there is a defect in specific regulatory mechanisms such as T reg cells, and there is still no fully satisfactory experimental model of coeliac disease. As a PhD student, I found that some aspects of the intestinal pathology such as crypt hyperplasia and increased numbers of intraepithelial lymphocytes could be reproduced in experimental animals by oral challenge with protein antigen after oral tolerance had been prevented 5 . This work has been extended in the past 15 years by findings that activation of the innate immune system by IL-15 may be an important mechanism allowing tolerance to be overcome. Together with RA, IL-15 may favour the generation of effector rather than regulatory CD4
+ T cells and also activate cytotoxic activity by intestinal intraepithelial lymphocytes (IEL), leading to epithelial cell death and increased uptake of antigenic peptides [115] [116] [117] [118] . IgE-mediated food allergies are among the diseases that have increased most in incidence in the past 40 years and there is more direct evidence that a breakdown in oral tolerance contributes to these ailments. For example, it has been known for some time that spontaneous remission from cow's milk allergy in children is accompanied by restoration of T reg cell numbers to normal levels 123 . Very recently, a substantial clinical trial showed that early exposure to peanut in the diet protected against the development of peanut-induced food allergy in at-risk children, clearly suggesting that oral tolerance had been induced by this protocol 124 . Interestingly, it has long been known that the induction of oral tolerance to prevent IgE responses against protein antigens in mice requires signals derived from the microbiota 125 , perhaps partly explaining how exposure to antibiotics early in life may lead to increased susceptibility to atopic disease 126 .
Oral tolerance-based therapy A number of animal models in the 1980s and 1990s suggested that oral tolerance could be exploited in the treatment of autoimmune disease, as feeding appropriate antigens was shown to prevent or even ameliorate established disease in experimental arthritis, type 1 diabetes, encephalomyelitis and other models of autoimmunity 7 . As well as targeting antigen-specific T cells directly, this approach was thought to have the advantage of inducing T reg cells that might inhibit the phenomenon of epitope spreading via their ability to produce bystander suppression of other T cell clones. On the basis of the promising animal work, clinical trials were carried out in the 1990s examining the use of oral tolerance in rheumatoid arthritis, multiple sclerosis, autoimmune uveitis and type 1 diabetes 127 . However, none of the trials was successful, and this idea has not been resurrected since. While it remains an attractive possibility, difficulties in identifying the appropriate auto-antigens and in establishing regimes that will interfere with established disease may well prevent this from becoming reality for autoimmune diseases. However, the recent work on peanut allergy and coeliac disease indicates that there could be scope in exploiting what appears to be a natural window for tolerance induction early in life for preventing disorders caused by inappropriate responses, for example, to food proteins.
Summary
Systemic tolerance to innocuous antigens was one of the first aspects of the intestinal immune system to be identified, and it is now accepted that it plays a crucial role in preventing disorders such as coeliac disease, IBD and food allergies. While we still do not understand the process in full, recent years have seen a number of important advances because of the rapid expansion of knowledge in cellular immunology. In the case of soluble antigens such as food proteins, it is now clear that the induction of tolerance requires specific populations of DCs that express CD103 and produce RA. It is likely that these DCs are derived from the villus lamina propria, where they acquire antigen by routes that are yet to be defined before migrating in lymph to meet naive T cells in the draining MLN. RA from the DCs drives the expression of gut-homing markers on T cells and induces their differentiation into FOXP3
+ T reg cells that recirculate back to the mucosa and maintain tolerance via the production of IL-10 and/or TGFβ. Mucosal macrophages may help maintain the local survival of T reg cells via the production of IL-10. The cellular events involved in tolerance to the microbiota are less clear, but the process appears to be limited to the intestine itself, and IL-10 clearly plays a crucial role in preventing inflammation in response to these antigens. In return, one of the most important developments in the field in the past 20 years has been the realization that the microbiota has dramatic effects on immune function throughout the body. Extending these insights at the cellular and molecular levels provides ample scope for research into the foreseeable future (Box 1).
Box 1 | Future questions for the field
• How do soluble antigens induce generalized tolerance, whereas tolerance to the microbiota is restricted to the intestine? • Are the cellular mechanisms of tolerance the same for these different forms of antigen?
• Do discrepancies between these processes relate to anatomical differences in the immune systems of the small and large intestine? • How can fundamental insights from mouse models be translated into the understanding of diseases such as coeliac disease and inflammatory bowel disease (IBD)? • Will oral tolerance be exploitable for treatment of autoimmune and inflammatory diseases?
• How do the microbiota and its products shape oral tolerance and systemic immunity, and what are the consequences of antibiotic use early in life on these processes?
